Haloacetic acids (HAs) are embryotoxic contaminants commonly found in drinking water. The mechanism of HA embryotoxicity has not been defined, but may be mediated in part by protein kinase C (PKC) inhibition. This study was conducted to evaluate the pathogenesis of HA embryotoxicity, and to compare these data with those from specific (Bis I) and non-specific (staurosporine) inhibitors of PKC. Embryos were incubated for varying times with several HAs, Bis I, staurosporine, or Bis V (a negative control). Cell cycle analysis was performed by flow cytometry following nuclear staining with propidium iodide; apoptosis was evaluated by fluorescence microscopy following LysoTracker staining. At concentrations producing 100% embryotoxicity with no embryolethality, only staurosporine perturbed the cell cycle. However, flow cytometry revealed accumulation of sub-G1 events (an apoptotic indicator) across time with bromochloroacetic acid, dichloroacetic acid, and staurosporine, but not dibromoacetic acid, Bis I, or Bis V. Sub-G1 events were particularly prominent in the head region, and remained at control levels in the heart. LysoTracker staining confirmed a similar pattern of apoptosis in the intact embryo; BCA and DCA produced intense staining in the prosencephalon, with virtually no staining in the heart. These data indicate that while cell-cycle perturbation may not mediate the pathogenesis of HA embryotoxicity, these agents do induce embryonic apoptosis. In addition, the lack of Bis I-induced apoptosis indicates that PKC inhibition is unlikely to be the sole mediator of HA embryotoxicity.
The potential adverse health effects associated with drinking water disinfection are a major public health concern (Bull et al., 1995) . Several drinking water disinfection byproducts, including the haloacetic acids (HAs), have been implicated in a variety of toxic effects, including carcinogenesis and developmental toxicity (Bull, 1992) ; the HAs perturb development both in vivo (Epstein et al., 1992; Smith et al., 1989 Smith et al., , 1992 and in whole-embryo culture . The embryo culture studies indicated that all of the HAs tested have the potential to perturb embryogenesis, primarily by adversely affecting neural-tube closure and craniofacial development, over a broad concentration range (1 to 3000 M). Additionally, a quantitative structure-activity relationship for the HAs revealed that the pKa and the energy of the lowest unoccupied molecular orbital (E lumo ) of the series of HAs examined best correlated with the observed embryotoxic effects . Since E lumo is related to the ability of the molecule to accept an electron and, thus, to reactivity, this relationship suggests that the embryotoxicity of the various HAs may share one or more common mechanism(s).
One potential mechanism by which the HAs may perturb development is inhibition of protein kinases. Dichloroacetate in particular has been shown to inhibit various protein kinases, including pyruvate dehydrogenase kinase (Crabb et al., 1981) , succinyl-CoA synthetase (Yang and Smith, 1983) , and protein kinase A and MAP kinase (Smith et al., 1997) . Also, it has recently been demonstrated that various HAs inhibit purified human protein kinase C (PKC) and PKC isolated from neurulation-stage mouse embryos (Ward et al., 1997) . Protein kinases, especially PKC, are important regulators of many different cellular events, including apoptosis (Leszczynski, 1996) and regulation of the cell cycle (Fishman et al., 1998) . Given the importance of these molecular processes in development (Elstein et al., 1993a; Knudsen, 1997) , it is intuitive that perturbation of PKC activity could result in dysregulation of critical events during development, to produce embryotoxicity.
The objective of this study was to describe the cellular pathogenesis of HA embryotoxicity in the neurulation-stage mouse. Whole-embryo culture was chosen as the experimental approach for this investigation because of the necessity to eliminate maternal influences (e.g., maternal toxicity or pharmacokinetics) in the study design, while retaining the structural and functional integrity of the embryo. Because of the potential role of HA-induced perturbations in PKC activity as a mechanism for the observed dysmorphogenicity, Bis I, a specific PKC inhibitor with previously defined embryotoxic effects (Toullec et al., 1991; Ward et al., 1998) was employed in this investigation as a comparator to the HAs. Also, as a positive control, the pathogenesis of staurosporine, a potent but nonspecific protein kinase inhibitor known to interact with the cell cycle (Bruno et al., 1992) and with apoptosis (Falcieri et al., 1993; Rajotte et al., 1992) , was investigated. Finally, Bis V, a structural analog of Bis I that possesses neither PKC-inhibitory activity (Davis et al., 1992) nor substantial embryotoxicity (Ward et al., 1998) was employed in this investigation as a negative control.
Whole embryo culture. Conceptuses were cultured in 30-mL serum bottles in culture medium consisting of 75% immediately centrifuged, heatinactivated rat serum and 25% Tyrode's buffer and test compound. Up to 5 embryos were cultured per bottle in 4 mL of medium; embryos from a given litter were randomly distributed among treatments and doses. Culture bottles were gassed using a mixture of 5% O 2 , 5% CO 2 , and 90% N 2 , and sealed with a silicon stopper. Bottles were placed onto a rotating wheel (30 rpm) in a 38°C incubator. For extended culture periods, cultures were re-gassed after 20 to 21 h of culture, using 20% O 2 , 5% CO 2 , and 75% N 2 .
For evaluation of staurosporine-induced dysmorphogenesis, staurosporine was dissolved in DMSO and added to the culture medium at various concentrations ranging from 0.005 to 0.1 M (N ϭ 6 to 9 embryos per staurosporine concentration). In no instance did the DMSO content in the culture system exceed 20 M; this concentration of DMSO produces no adverse effects in rat or mouse whole-embryo culture (Kitchin and Ebron, 1984; Ward et al., 1998) . Appropriate control embryos were incubated with identical concentrations of DMSO to the staurosporine-treated embryos (N ϭ 9). At the end of 24 to 26 h of culture, embryos were evaluated for dysmorphogenesis according to previously defined criteria (Sadler and Warner, 1984) , including an evaluation of craniofacial structures, as well as heart and somite morphology. In embryos lacking a detectable heartbeat, the embryo was classified as dead and excluded from morphological evaluations.
Effect of test compounds on cell cycle regulation. To evaluate whether the test compounds altered the cell cycle in the neurulation-stage embryo, flow cytometry was used to assess the percentage of cells that were in different stages of the cell cycle (i.e., G0/G1, S, or G2/M). Embryos were cultured for 6 (gd 8.25), 12 (gd 8.5), 18 (gd 8.75), or 24 h (gd 9) in the presence or absence of DCA (11000 M), DBA (300 M), BCA (300 M), Bis I (10 M), or Bis V (10 M), or for 8 (gd 8.33), 18 (gd 8.75), or 24 h (gd 9) in the presence of staurosporine (0.1 M). The test agents were assessed independently. Each agent was dissolved in deionized water (with the exception of staurosporine and Bis V, which were dissolved in DMSO) and added to the culture medium to give the desired concentration. Concentrations of each test compound used were selected in order to produce 100% embryotoxicity with no consequent embryolethality, except for Bis V, which was used at the same concentrations as Bis I to facilitate a direct comparison Ward et al., 1998) . At the end of the culture period, embryos were removed from the culture system and the visceral yolk sac was removed.
Embryos were either used whole or were dissected into 4 segments: head (including both pharyngeal arches and the otic anlagen), heart, midpiece (from the otic anlagen to approximately the midpoint of the body), and hindpiece, and appropriate segments from 6 to 12 embryos were pooled for analysis. Cell cycle analysis was conducted using a FACSCalibur flow cytometer (BectonDickinson, San Jose, CA) essentially as described by Elstein and Zucker (1997) . Briefly, immediately upon collection, embryo segments were placed in 1 mL of phosphate-buffered saline containing 10% DMSO and 10% fetal bovine serum. Samples were cooled at 4°C for approximately 30 min, then stored overnight at -20°C before final storage at -80°C until analysis. On the day of analysis, embryos were thawed at 37°C and all excess buffer was removed. Each sample was triturated with 20 strokes of a fine-tipped plastic pipet in 0.5 mL of lysing buffer (phosphate-buffered saline (pH 7.4) containing 0.2% NP-40 and 0.5 mg/mL RNAse A). Samples were allowed to incubate at room temperature for 30 min, and then were placed on ice, where they were kept for the remainder of analysis. At the end of the incubation period, 25 L of propidium iodide (1 mg/mL) was added to each 0.5-mL sample; samples were vortexed immediately after addition of stain. Red fluorescence of Ն10,000 nuclei was detected using 488-nm excitation, a 630-nm Schott barrier filter, and doublet discrimination. The percentage of cells in each phase of the cell cycle was calculated using the ModFit 2.0 LT software package (BectonDickinson, San Jose, CA).
Effect of test compounds on embryonic apoptosis. To evaluate whether the test compounds altered patterns of embryonic cell death, fluorescence microscopy was employed. Embryos (N ϭ 6 to 12 per treatment group) were cultured for 24 h in the presence or absence of DCA, DBA, BCA, Bis I, or Bis V as described for cell cycle analysis above. After 24 h of culture, embryos were removed from the culture system and the visceral yolk sac was removed. For a qualitative determination of apoptosis, the acidophilic dye LysoTracker Red (LT) was employed. LT consists of a fluorophore moiety linked to a weak base that is only partially protonated at neutral pH; it is freely permeant to cell membranes and preferentially accumulates in acidic environments, such as with lysosomes (Haugland, 1996) . Because one hallmark of cells undergoing apoptosis is cytoplasmic acidification (Lincz, 1998; Meisenholder et al., 1996) , and also because cells neighboring regions of apoptosis may display enlargement/activation of lysosomes as they phagocytose apoptotic bodies, LT staining has been used as a marker of apoptosis Lau et al., 1998; Zucker et al., 1997) . The LT staining procedure was similar to that described by Zucker and co-workers (1998) . Essentially, after removal of the yolk sac, whole embryos were shaken and incubated in 5 M LT for 30 min at 37°C and then fixed in 2% paraformaldehyde in phosphate buffered saline at 4°C for 12 h. Following fixation, embryos were stored at 4°C in a tightly sealed container until analysis. Embryos were visualized using a Leica fluorescence microscope (Leica MZ12 stereofluorescence microscope, 100-W Hg bulb) with a green fluorescence filter module (546/10 nm excitation filter; dichromatic beam splitter, 565 nm; Barrier filters OG 590 nm) and photographed with a Dage MTI CCD-300T-RC camera. A Scion video capture card was used in a Macintosh 7100 computer. Images were averaged for 16 frames before capture. Adobe Photoshop 5.0.2 was used for creating the figures of embryo images. Figures were printed on a Codonics 1600 printer.
Statistical analysis.
The percentage of cells in each phase of the cell cycle, in embryos exposed at different times to each agent, was compared to timematched control embryos using either a 1-way analysis of variance (ANOVA) with a Bonferroni correction for multiple comparisons or a 2-tailed Student's t-test, as noted below. The level of statistical significance of differences was predetermined as p Յ 0.05 for all comparisons. Table 1 contains the results of the experiments evaluating the dysmorphogenicity of staurosporine in mouse wholeembryo culture. Previously reported dysmorphogenicity data for the other test compounds evaluated in this investigation are also included for comparison Ward et al., 1998) , with the exception of BCA (Hunter et al., manuscript in preparation) . All embryos grown in control medium developed normally in this study; these embryos averaged 22.2 Ϯ 1.2 somite pairs at the end of the 1-day culture period. In contrast, exposure of mouse embryos to staurosporine at concentrations ranging from 0.075 to 0.1 M produced a variety of adverse developmental effects. In general, the incidence of malformations increased with increasing concentration of staurosporine in the medium. The heart and pharyngeal arches appeared most susceptible to staurosporine-induced effects. When a 0.05-or 0.10-M concentration was employed, 100% of embryos exhibited malformations when compared to age-comparable control embryos. These malformations included incomplete embryonic rotation, lack of cranial neural tube closure, prosencephalic hypoplasia, abnormally shaped eye anlagen, and abnormal development of the heart. The average number of somite pairs in the embryos exposed to 0.05 or 0.10 M staurosporine at the end of culture was 17.0 Ϯ 4.8 or 13.2 Ϯ 3.2, respectively. These values were significantly lower than in control embryos (p ϭ 0.0014, one-way ANOVA with Bonferroni correction). Abnormal development of the yolk sac (i.e., incomplete expansion and/or decreased vascularization compared to controls), also was observed at this staurosporine concentration. DCA also demonstrated yolk sac effects at the concentration employed ; none of the other test compounds appeared to produce abnormalities in the yolk sac. Figure 1 summarizes the result of experiments designed to describe the time course of the effect of various test agents on the percentage of embryonic cells in each stage of the cell cycle. As anticipated, staurosporine altered the cell cycle distribution in the neurulation-stage embryo. After 8, 18, and 24 h of culture, staurosporine-treated embryos displayed significantly lower percentages of cells in S phase, and significantly greater percentages of cells in G1 compared to controls (p Ͻ 0.0002, 2-tailed Student's t-test). The percentage of cells in G2/M was unaffected by staurosporine treatment. In contrast, in whole-embryo homogenates, no significant differences were noted in the percentage of cells in each phase of the cell cycle with any treatment at any time point. The only notable difference across the various treatment groups was the apparent asynchrony of the DCA-treated embryos as compared to the other groups. In controls, as well as embryos treated with DBA, BCA, Bis I, and Bis V, the percentage of embryonic cells in the S and G2/M phases tended to rise at 12 h, while the percentage in G1 declined. An opposite pattern was observed for DCA-treated embryos; the percentage of cells in the G1 phase increased at 12 h, while the percentage in the S or G2/M phases declined or remained constant (Fig. 1) . This difference, however, was not statistically significant at any of the time points examined. Although a detailed morphological analysis was not performed on each embryo at each time point examined, the incidence and types of developmental abnormalities displayed in these embryos were consistent with those reported previously for these test agents Ward et al., 1998) . Given the lack of effect on the cell cycle in the presence of overt embryotoxicity for all compounds except staurosporine, it was hypothesized that regional alterations in the cell cycle within the embryo could be masked by opposite changes in other portions of the embryo, or that changes in relatively small cell populations could be occluded by the overall mass of the embryo. Thus, experiments were conducted to evaluate the cell-cycle pattern of different regions of the embryo after 24 h of incubation with the test compounds. The resulting data for the head and the heart regions are displayed in Figure 2 ; the midpiece and hindpiece regions demonstrated a similar cell cycle distribution (data not shown). No significant differences from controls were observed in the cell cycle of any given embryonic region with any test agent (staurosporine was not examined). Interestingly, however, the regional cell cycle data for the hearts of DCA-treated embryos appeared somewhat different from the other test compounds. The percentage of cells in G1 was lower than controls or the other treatment groups, while the percentage in S phase was greater, although the magnitude of these differences did not achieve the level of statistical significance (p ϭ 0.17 and 0.10 for G1 and S phase, respectively; one-way ANOVA across all groups with Bonferroni correction for multiple comparisons).
RESULTS
Despite the apparent lack of effect observed within any treatment group (aside from staurosporine) on the cell cycle of the developing embryo, HA treatment was associated with an important alteration in the overall embryonic flow cytometry data. Figure 3 demonstrates that various treatments were associated with an increase in sub-G1 events (i.e., a hypodiploid peak; cells or cellular debris with less than 2 n copy of DNA) in the embryo at each time point examined. None of these differences was statistically significant after 6 h of incubation (large variability in the DCA group precluded achievement of statistical significance). However, at subsequent time points, both DCA and BCA, but not DBA, Bis I, or Bis V, produced significant increases in sub-G1 events (p Ͻ 0.0001; one-way ANOVA with a Bonferroni post-hoc correction). Staurosporine   FIG. 2 . Region-specific effect of HA, Bis I, or Bis V treatment on the embryonic cell cycle in the head region (top panel) or the heart (bottom panel). Bars represent the mean percentage of cells in each phase of the cell cycle from 3 to 7 determinations using pooled regional homogenates from 6 to 12 different embryos each.
FIG. 1.
Time course of effect on the cell cycle in whole-embryos treated with various HAs, staurosporine, Bis I, or Bis V. Control embryos, •; 10 M Bis I, E; 10 M Bis V, ࡗ; 0.1 M staurosporine, OE; 300 M DBA, छ; 300 M BCA, ‚; 11,000 M DCA, ᮀ. Each symbol represents the mean of 3 to 30 separate determinations using pooled homogenates from 6 to 12 different embryos per determination; error bars not shown for clarity. treatment produced a significant induction of sub-G1 events in whole-embryo homogenates at each time point examined compared to controls (p Ͻ 0.0001; 1-way ANOVA). In addition to the whole-embryo homogenates, isolated embryo segments treated with Bis I, Bis V, or the HAs also were analyzed for sub-G1 events after 24 h of culture (Fig. 4) . A one-way ANOVA revealed a significant difference in the incidence of sub-G1 events in each embryonic region across treatment groups. However, a Bonferroni post-hoc comparison between each treatment group did not achieve statistical significance for any one treatment group compared to controls for the head region, midpiece, or hindpiece. Despite the lack of statistical significance, it was apparent that BCA and DCA treatments were associated with substantial increases in sub-G1 events in most regions. In contrast to the other regions, the heart did demonstrate a significant induction of sub-G1 events with DCA treatment (p ϭ 0.04, one-way ANOVA across treatment groups with Bonferroni post-hoc comparison).
Finally, given the presence of sub-G1 events in the neurulation-stage embryo treated with the test agents, the possibility of alterations in embryonic apoptosis was considered in follow-up studies. Alterations in patterns of apoptosis were evaluated using fluorescence microscopy following LysoTracker Red staining; these data are displayed in Figure 5 . The image analysis data generally were in good agreement with the sub-G1 event data derived from flow cytometry. In control embryos, evidence of a basal level of ongoing apoptosis was noted in the head region, particularly in the region of the trigeminal ganglion; these data are consistent with in vivo embryonic cell-death patterns observed previously (Blaschke et al., 1998) . Increased intensity of LysoTracker staining was observed with HA-treated embryos, especially in the optic anlagen, the prosencephalon, and the branchial arches. In general, agreement with the flow cytometry data, no evidence of increased staining was noted in the heart with treatment with the test compounds. In contrast, culture of embryos for 24 h   FIG. 3 . Time course of the production of sub-G1 events in whole embryos treated with various HAs, staurosporine, Bis I, or Bis V. Control embryos, •; 10 M Bis I, E; 10 M Bis V, ࡗ; 0.1 M staurosporine, OE; 300 M DBA, छ; 300 M BCA, ‚; 11,000 M DCA, ᮀ. Each symbol represents the mean of 3 to 30 separate determinations using pooled homogenates from 6 to 12 different embryos per determination; error bars not shown for clarity. * Significantly different from control embryos.
FIG. 4.
Region-specific effect of HA, Bis I, or Bis V treatment on the production of sub-G1 events in specific embryonic regions. Data are presented as mean Ϯ SD of the incidence of sub-G1 events from 3 to 7 determinations using pooled regional homogenates from 6 to 12 different embryos each.
with Bis I treatment resulted in a similar pattern of LysoTracker staining as observed in the control embryos, further suggesting the lack of induction of apoptosis with this toxicant.
DISCUSSION
This investigation incorporated data on 2 different, but potentially interrelated, mechanistic endpoints for the developmental toxicity of the HAs. First, the cell cycle distribution in CD-1 mouse embryos at gd 8.25, gd 8.5, and gd 9 was examined. In the developing embryo, the majority (about 55%) of control embryonic cells at each gestational stage examined were in S phase, with approximately 35% and 10% in the G1 and G2/M phases, respectively. These data are consistent with the active cellular division ongoing within the embryo at this developmental stage, and are similar to those reported by Elstein and co-workers (1993b) in gd-10 Sprague-Dawley rat embryos (about 55% of cells in whole-embryo homogenates in S phase) and by Peeters and co-workers (1998) in isolated tail buds of several mouse strains (21 to 25 somites; approximately 50% in S phase, 35% in G0/G1, and 15% in G2/M). In homogenates of whole embryos analyzed by flow cytometry, no significant changes were observed in the percentage of cells in each phase of the cell cycle in any treatment group except staurosporine, even though each embryo in each treatment group manifested profound dysmorphology. Furthermore, no changes in the cell cycle were noted with HA treatment when specific regions of the embryo were isolated and examined by flow cytometry. These data suggest that the HAs do not act through perturbation of the cell cycle to produce their adverse effects on the conceptus.
In contrast, however, flow cytometry did reveal substantial accumulation of sub-G1 events in whole-embryo homogenates treated with the HAs. Because of the characteristic intranucleosomal DNA cleavage that occurs during apoptosis, sub-G1 peaks may be used as a flow cytometric marker of apoptosis (Hanon et al., 1996; McCarthy and Evan, 1998) . While DBA was not a potent inducer of sub-G1 events, both BCA and DCA did produce an increased incidence of sub-G1 peaks in wholeembryo homogenates. For BCA, this induction appeared to exclude the heart region of the embryo; this result was confirmed using LysoTracker staining and fluorescence microscopy. Because the predominant morphologic effect of the HAs in whole-embryo culture is induction of neural tube defects, these data are suggestive of a mechanistic linkage between induction of apoptosis and HA embryotoxicity. These data also are consistent with previous investigations demonstrating that the heart of the neurulation-stage mouse embryo is relatively resistant to the induction of apoptosis by various developmental toxicants (Mirkes and Little, 1998) .
Although the effects of DCA were generally similar to those observed with BCA (i.e., induction of apoptosis with no concomitant change in the cell cycle), some differences were observed between DCA and the other test agents. DCA pathogenesis was characterized by an apparent subtle pattern shift in the time course of the cell-cycle data; percentage of cells in S phase rose and fell across time differently after treatment with DCA than with the other toxicants. This effect was even more pronounced in the region-specific data; DCA appeared to induce a shift in the population of cells towards S phase in the heart, and towards G1 in the head region. Furthermore, DCA induced cardiac apoptosis in addition to apoptosis in the head region. Several possibilities exist which may explain these data. First, it is important to note that in general, DCA is a weaker embryotoxicant than many of the other HAs. The benchmark concentration (the calculated lower 95% confidence interval for production of 5% incidence of neural tube defects) for DCA toxicity is about 2500 M, compared to about 150 M for DBA . Similarly, to obtain a test cohort of embryos in which 100% embryotoxicity was produced, DCA had to be administered at 11 mM, as opposed to 300 M for both BCA and DBA. This large difference in benchmark concentrations alone is suggestive of a potentially different mechanism of action for DCA. Second, it is possible that decreased intracellular pH resulting from the relatively large concentration of DCA employed may have produced a general effect on the embryo not present with the other test compounds. Although the pH of the embryo culture medium does not decrease significantly with inclusion of 11 mM DCA , the intracellular embryonic pH is unknown, and may have played a role in the effects observed in the present study. Finally, DCA is a well-characterized in vivo developmental cardiotoxicant in the rat (Epstein et al., 1992; Smith et al., 1992) ; the developmental cardiotoxicity of other HAs has not been fully characterized.
It may be that the observed induction of apoptosis in the heart in whole-embryo culture (as determined by the increase in sub-G1 events) is a more sensitive indicator of eventual developmental cardiotoxicity than simple gross morphological examination alone at this developmental stage, and that the observed increase in apoptosis is a precursor to later dysmorphogenesis. Further research is required to more thoroughly characterize the differences between DCA-induced pathogenesis and that induced by other HAs. Interestingly, the observed induction of embryonic apoptosis by DCA contrasts with work by Snyder and co-workers (1995) , who demonstrated that DCA (0.5 and 5 g/L in drinking water) significantly decreased hepatocellular apoptosis in vivo. These data indicate that DCA may interact with the whole embryo by a different mechanism than that acting in the liver; alternatively, the lower dosage of DCA administered in vivo may underlie this discrepancy. Further research will be necessary to clarify these findings.
In this investigation, DCA and BCA increased apoptosis with no concomitant alteration in cell cycle pattern. The complex and sometimes contradictory interaction between induction of apoptosis and changes in the cell cycle has been investigated previously (King and Cidlowski, 1998) . Some toxicants have been demonstrated to produce both changes in apoptosis and alterations in the cell cycle, while other toxicants may affect either endpoint. For example, zinc deficiency and ethanol appear to induce embryonic apoptosis with no parallel change in the cell cycle (Cartwright et al., 1998; Rogers et al., 1995) ; the hypolipidemic drug nafenopin perturbs the cell cycle but not apoptosis (Elcock et al., 1998) ; and methyl tertiary butyl ether and 5-aza-2Ј-deoxycytidine appear to affect both endpoints simultaneously (Rogers et al., 1994; Vojdani et al., 1997) . Furthermore, Park and co-workers (1997) have demonstrated that cell-cycle blockers such as deferoxamine and mimosine actually suppress camptothecin-induced apoptosis in vitro. The present data, demonstrating an effect of DCA and BCA on apoptosis with no change in the cell cycle, lend further support to the hypothesis that cell cycle alterations are not necessary precursors to apoptosis. This hypothesis, by extension, would suggest that both apoptosis and the cell cycle warrant investigation as cellular markers of toxicity, since it is not obvious a priori whether a toxicant will induce changes in the cell cycle, apoptosis, both, or neither.
Previously, the embryotoxicity of staurosporine has been characterized in rat, but not mouse, embryos (Fujinaga et al., 1994) . In the present investigation in mouse embryos, the predominant dysmorphogenic effects of staurosporine were observed in the pharyngeal arch, eye, and heart. These data differed from the previously described effects of staurosporine in rat embryos. Mesencephalic vesicles, observed in staurosporine-treated rat embryos, were not observed in staurosporine-treated mouse embryos in the present study. Also, the concentration required to attain approximately 100% incidence of embryotoxicity was greater in the rat than in the mouse. However, this apparent difference in sensitivity may be due in part to differences in experimental design. Fujinaga and coworkers (1994) exposed egg cylinder-stage rat conceptuses for 4 h to staurosporine at concentrations Ն0.1 M, since exposure for the full 50-h culture period was embryolethal. In the present investigation, developmentally older neurulation-stage mouse embryos were exposed to staurosporine at concentrations Յ 0.1 M for the entire 24-to 26-h culture period.
From a biochemical standpoint, the staurosporine data from the present investigation are consistent with data from the literature. Staurosporine is well-characterized as an agent that both induces apoptosis and alters the cell cycle distribution in a variety of cell types and under many different conditions (Courage et al., 1996; Qiao et al., 1996; Stokke et al., 1997; Swe and Sit, 1997) . The observations in the present study are consistent with these previous findings. In particular, staurosporine is associated with a G1 blockade (Orr et al., 1998; Wang and Xue, 1997) , a finding also consistent with the increase in the percentage of embryonic cells in G1 in the present investigation.
In contrast to the staurosporine data, the lack of effect of Bis I on the cell cycle or apoptosis in the present study was less anticipated. Effects of Bis I on the modulation of apoptosis and the cell cycle have been demonstrated in a variety of systems. These include G1-phase arrest in C6 glioma cells (O'Brien and Regan, 1998) and prevention of cerebellar granule cell apoptosis (Villalba, 1998) . These data, along with the present findings, suggest that Bis I may interact with embryonic cells in whole-embryo culture differently from those previously studied in in vitro systems, or that some of the in vitro effects mediated by Bis I are compensated for by the developing organism. It has been previously demonstrated that staurosporine, but not Bis I, induces apoptosis in isolated rat thymocytes, indicating that PKC may not be involved in the production of apoptosis in the developing embryo by staurosporine (Harkin et al., 1998) . One further potential mechanism for the apparent lack of effect of Bis I on embryonic apoptosis or the cell cycle could be the PKC isozyme distribution in the neurulation-stage mouse embryo. Previously, it has been reported that atypical (i.e., calcium/phospholipid-independent) PKC isoforms predominate in the mouse embryo at this developmental stage (Ward et al., 1997) . Bis I possesses less affinity for the atypical isoforms of PKC than for the classical isozymes (Gescher, 1998) ; this isozyme specificity may underlie the lack of effect of Bis I on these endpoints in the mouse embryo.
In summary, this investigation has generated data indicating that the embryotoxicity of certain HAs may be mediated, in part, by modulation of apoptosis, without concomitant cell cycle perturbations. Furthermore, the dysmorphogenic effects of staurosporine, a broad-spectrum protein kinase inhibitor, were evaluated in the mouse embryo; the staurosporine-treated embryos served as positive controls for induction of apoptosis and changes in the cell cycle distribution. Finally, the effects of Bis I, a specific PKC inhibitor, were investigated; neither alterations in apoptosis nor effects in the cell cycle could be invoked to explain the observed dysmorphogenesis induced by this agent. Future research will be directed towards a more thorough investigation of the role of various signal transduction pathways in the neurulation-stage embryo, with a particular emphasis on elucidating the mechanism(s) by which Bis I may exert its toxic effect. Specific future experiments may include a determination of the contribution of the different isozymes of PKC in the neurulation-stage embryo, as well as evaluation of the role of other important signal transduction mechanisms, such as MAP kinase, in neurulation (Ward et al., 1997) . Finally, efforts also will be focused on a direct determination of the ability of the HAs, and perhaps other common environmental toxicants, to inhibit isozymes of PKC and/or other critical kinases involved in embryonic signal transduction.
